Biochemical pharmacologyAnimalsEncephalomyelitisAutoimmuneExperimentalTelomerase
Therapeutic effects of telomerase-derived peptide GV1001 in experimental autoimmune encephalomyelitis: Inhibiting neuroinflammation and promoting remyelination.
Jong-Heon Kim, Anup Bhusal, Jiwon Kwon, Jun-Yeong Lee, Min-Soo Song, Won-Ha Lee, Long Tai Zheng, Sangjae Kim, Kyoungho Suk
Published: 202610.1016/j.bcp.2025.117514
Abstract
GV1001, a peptide derived from human telomerase reverse transcriptase, exhibits anti-cancer and anti-inflammatory actions, yet its impact on experimental autoimmune encephalomyelitis (EAE)-an established mouse model of multiple sclerosis-remains unkn…
Preview only. Read the full abstract at the source